SEARCH
Biogen shares soar on Alzheimer's drug developments - 1breakingnews.com
1BN
2022-09-28
Views
12
Description
Share / Embed
Download This Video
Report
A study found that Biogen's Alzheimer's drug lecanemab reduced cognitive and functional decline by 27% compared to a placebo over an 18-month period.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8e1sk6" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:23
New Alzheimer's Drug From Biogen and Eisai Is Just the Beginning - 1breakingnews.com
00:40
Biogen And Eisai To Move Forward With Alzheimer's Research
00:33
104952-mainHouse investigation faults FDA, Biogen for Alzheimer's drug approval - 1breakingnews.com
03:34
Can Nose-Picking Raise Alzheimer's Dementia Risk? Here's What This Study Really Said - 1breakingnews
01:00
El nuevo fármaco de Biogen y Eisai frena el deterioro cognitivo producido por alzhéimer
02:00
Biogen to ship Alzheimer's drug in two weeks
03:10
Biogen Stock Rockets To Record High On Alzheimer's Drug Approval; 5
01:54
Biogen stock increases as Alzheimer's drug shows promise in early results of study - 1breakingnews.c
03:30
FDA approves controversial Biogen Alzheimer's drug _ DW News
02:00
Biogen to ship Alzheimer's drug in two weeks
02:17
Biogen Plunges After FDA Says No to Alzheimer's Treatment
04:40
Eli Lilly's Alzheimer's moment has arrived after Biogen plows through the
